West Pharmaceutical Services current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
West Pharmaceutical Services's current ratio is 2.82: current assets of 1.82B USD against current liabilities of 644.30M USD due within a year.
- Today
- 2.82
- Average, 5 years
- 3.04
- Low, 5 years
- 2.34
- High, 5 years
- 3.80
Current ratio = current assets ÷ current liabilities = 1.82B ÷ 644.30M = 2.82
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 2.82 | 1.82B | 644.30M | |
| FY2025 | 31 Dec 2025 | 3.02 | 1.98B | 654.90M |
| FY2024 | 31 Dec 2024 | 2.79 | 1.54B | 550.40M |
| FY2023 | 31 Dec 2023 | 2.88 | 1.94B | 671.80M |
| FY2022 | 31 Dec 2022 | 3.70 | 1.92B | 519.00M |
| FY2021 | 31 Dec 2021 | 2.93 | 1.74B | 594.10M |
| FY2020 | 31 Dec 2020 | 2.73 | 1.37B | 503.40M |
| FY2019 | 31 Dec 2019 | 3.10 | 1.06B | 341.60M |
| FY2018 | 31 Dec 2018 | 3.15 | 894.40M | 283.70M |
| FY2017 | 31 Dec 2017 | 2.66 | 743.50M | 279.50M |
| FY2016 | 31 Dec 2016 | 2.66 | 641.90M | 241.00M |
| FY2015 | 31 Dec 2015 | 2.14 | 673.70M | 314.30M |
| FY2014 | 31 Dec 2014 | 2.61 | 659.30M | 252.50M |
| FY2013 | 31 Dec 2013 | 2.75 | 650.70M | 236.90M |
| FY2012 | 31 Dec 2012 | 2.13 | 557.30M | 261.80M |
| FY2011 | 31 Dec 2011 | 1.94 | 472.00M | 243.20M |
| FY2010 | 31 Dec 2010 | 2.57 | 436.60M | 169.70M |
| FY2009 | 31 Dec 2009 | 2.32 | 397.20M | 171.10M |
| FY2008 | 31 Dec 2008 | 2.30 | 366.20M | 159.10M |
| FY2007 | 31 Dec 2007 | 2.25 | 412.30M | 182.90M |
| FY2006 | 31 Dec 2006 | 1.80 | 281.70M | 156.90M |
| FY2005 | 31 Dec 2005 | 1.90 | 237.20M | 124.80M |
| FY2004 | 31 Dec 2004 | 1.94 | 226.50M | 116.50M |
| FY2003 | 31 Dec 2003 | 1.82 | 216.70M | 118.90M |
| FY2002 | 31 Dec 2002 | 1.84 | 161.30M | 87.70M |
| FY2001 | 31 Dec 2001 | 2.10 | 158.50M | 75.30M |
| FY2000 | 31 Dec 2000 | 2.18 | 173.10M | 79.30M |
| FY1999 | 31 Dec 1999 | 1.78 | 184.70M | 104.00M |
| FY1998 | 31 Dec 1998 | 1.53 | 159.70M | 104.20M |
| FY1997 | 31 Dec 1997 | 2.94 | 170.70M | 58.00M |
| FY1996 | 31 Dec 1996 | 2.39 | 156.70M | 65.60M |
| FY1995 | 31 Dec 1995 | 2.40 | 148.40M | 61.80M |
| FY1994 | 31 Dec 1994 | 1.58 | 136.70M | 86.30M |
| FY1993 | 31 Dec 1993 | 1.99 | 93.20M | 46.80M |
| FY1992 | 31 Dec 1992 | 1.62 | 98.70M | 60.90M |
| FY1991 | 31 Dec 1991 | 1.37 | 97.40M | 70.90M |
| FY1990 | 31 Dec 1990 | 1.56 | 101.20M | 64.70M |
| FY1989 | 31 Dec 1989 | 2.07 | 97.40M | 47.00M |
| FY1988 | 31 Dec 1988 | 2.22 | 96.50M | 43.50M |
| FY1987 | 31 Dec 1987 | 2.01 | 89.90M | 44.70M |
| FY1986 | 31 Dec 1986 | 1.83 | 78.50M | 42.90M |
| FY1985 | 31 Dec 1985 | 3.47 | 56.50M | 16.30M |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 2.82 | 1.82B | 644.30M |
| Q2 FY2026 | 30 Jun 2026 | 2.82 | 1.81B | 640.50M |
| Q1 FY2026 | 31 Mar 2026 | 2.71 | 1.83B | 674.00M |
| Q4 FY2025 | 31 Dec 2025 | 3.02 | 1.98B | 654.90M |
| Q3 FY2025 | 30 Sept 2025 | 2.87 | 1.82B | 635.40M |
| Q2 FY2025 | 30 Jun 2025 | 2.78 | 1.68B | 604.60M |
| Q1 FY2025 | 31 Mar 2025 | 2.77 | 1.46B | 526.70M |
| Q4 FY2024 | 31 Dec 2024 | 2.79 | 1.54B | 550.40M |
| Q3 FY2024 | 30 Sept 2024 | 3.00 | 1.55B | 516.50M |
| Q2 FY2024 | 30 Jun 2024 | 2.34 | 1.48B | 633.70M |
| Q1 FY2024 | 31 Mar 2024 | 2.61 | 1.69B | 648.40M |
| Q4 FY2023 | 31 Dec 2023 | 2.88 | 1.94B | 671.80M |
| Q3 FY2023 | 30 Sept 2023 | 3.70 | 1.97B | 533.50M |
| Q2 FY2023 | 30 Jun 2023 | 3.66 | 1.87B | 511.60M |
| Q1 FY2023 | 31 Mar 2023 | 3.62 | 1.94B | 534.90M |
| Q4 FY2022 | 31 Dec 2022 | 3.70 | 1.92B | 519.00M |
| Q3 FY2022 | 30 Sept 2022 | 3.80 | 1.73B | 456.70M |
| Q2 FY2022 | 30 Jun 2022 | 3.13 | 1.77B | 565.10M |
| Q1 FY2022 | 31 Mar 2022 | 2.89 | 1.69B | 584.80M |
| Q4 FY2021 | 31 Dec 2021 | 2.93 | 1.74B | 594.10M |
| Q3 FY2021 | 30 Sept 2021 | 2.86 | 1.60B | 558.60M |
| Q2 FY2021 | 30 Jun 2021 | 3.13 | 1.48B | 472.60M |
| Q1 FY2021 | 31 Mar 2021 | 2.75 | 1.33B | 482.80M |
| Q4 FY2020 | 31 Dec 2020 | 2.73 | 1.37B | 503.40M |
| Q3 FY2020 | 30 Sept 2020 | 2.77 | 1.24B | 447.70M |
| Q2 FY2020 | 30 Jun 2020 | 2.96 | 1.11B | 375.20M |
| Q1 FY2020 | 31 Mar 2020 | 2.84 | 977.50M | 344.40M |
| Q4 FY2019 | 31 Dec 2019 | 3.10 | 1.06B | 341.60M |
| Q3 FY2019 | 30 Sept 2019 | 3.00 | 1.00B | 335.00M |
| Q2 FY2019 | 30 Jun 2019 | 3.02 | 944.30M | 313.20M |
| Q1 FY2019 | 31 Mar 2019 | 2.88 | 867.60M | 301.10M |
| Q4 FY2018 | 31 Dec 2018 | 3.15 | 894.40M | 283.70M |
| Q3 FY2018 | 30 Sept 2018 | 2.94 | 850.10M | 288.80M |
| Q2 FY2018 | 30 Jun 2018 | 2.67 | 766.90M | 287.60M |
| Q1 FY2018 | 31 Mar 2018 | 2.82 | 743.50M | 263.40M |
| Q4 FY2017 | 31 Dec 2017 | 2.66 | 743.50M | 279.50M |
| Q3 FY2017 | 30 Sept 2017 | 2.59 | 776.90M | 300.00M |
| Q2 FY2017 | 30 Jun 2017 | 2.48 | 717.80M | 289.00M |
| Q1 FY2017 | 31 Mar 2017 | 2.54 | 652.60M | 256.50M |
| Q4 FY2016 | 31 Dec 2016 | 2.66 | 641.90M | 241.00M |
| Q3 FY2016 | 30 Sept 2016 | 2.78 | 658.10M | 236.80M |
| Q2 FY2016 | 30 Jun 2016 | 2.75 | 659.20M | 239.40M |
| Q1 FY2016 | 31 Mar 2016 | 2.62 | 630.70M | 241.10M |
| Q4 FY2015 | 31 Dec 2015 | 2.14 | 673.70M | 314.30M |
| Q3 FY2015 | 30 Sept 2015 | 2.27 | 680.90M | 299.90M |
| Q2 FY2015 | 30 Jun 2015 | 2.17 | 679.90M | 313.70M |
| Q1 FY2015 | 31 Mar 2015 | 2.11 | 625.10M | 296.60M |
| Q4 FY2014 | 31 Dec 2014 | 2.61 | 659.30M | 252.50M |
| Q3 FY2014 | 30 Sept 2014 | 2.80 | 679.50M | 242.50M |
| Q2 FY2014 | 30 Jun 2014 | 3.10 | 685.40M | 221.20M |
| Q1 FY2014 | 31 Mar 2014 | 3.02 | 686.60M | 227.60M |
| Q4 FY2013 | 31 Dec 2013 | 2.75 | 650.70M | 236.90M |
| Q3 FY2013 | 30 Sept 2013 | 2.61 | 643.50M | 246.80M |
| Q2 FY2013 | 30 Jun 2013 | 2.80 | 613.30M | 218.70M |
| Q1 FY2013 | 31 Mar 2013 | 2.83 | 589.70M | 208.10M |
| Q4 FY2012 | 31 Dec 2012 | 2.13 | 557.30M | 261.80M |
| Q3 FY2012 | 30 Sept 2012 | 2.02 | 557.30M | 275.60M |
| Q2 FY2012 | 30 Jun 2012 | 1.61 | 517.00M | 320.20M |
| Q1 FY2012 | 31 Mar 2012 | 1.66 | 502.80M | 302.40M |
| Q4 FY2011 | 31 Dec 2011 | 1.94 | 472.00M | 243.20M |
| Q3 FY2011 | 30 Sept 2011 | 2.20 | 503.50M | 229.30M |
| Q2 FY2011 | 30 Jun 2011 | 2.65 | 510.40M | 192.70M |
| Q1 FY2011 | 31 Mar 2011 | 2.63 | 481.10M | 182.80M |
| Q4 FY2010 | 31 Dec 2010 | 2.57 | 436.60M | 169.70M |
| Q3 FY2010 | 30 Sept 2010 | 2.79 | 441.20M | 158.20M |
| Q2 FY2010 | 30 Jun 2010 | 2.55 | 403.90M | 158.60M |
| Q1 FY2010 | 31 Mar 2010 | 2.20 | 404.90M | 183.80M |
| Q4 FY2009 | 31 Dec 2009 | 2.32 | 397.20M | 171.10M |
| Q3 FY2009 | 30 Sept 2009 | 2.45 | 399.10M | 162.80M |
| Q2 FY2009 | 30 Jun 2009 | 2.45 | 396.20M | 161.50M |
| Q1 FY2009 | 31 Mar 2009 | 2.57 | 356.20M | 138.70M |
| Q4 FY2008 | 31 Dec 2008 | 2.30 | 366.20M | 159.10M |
| Q3 FY2008 | 30 Sept 2008 | 2.48 | 410.50M | 165.50M |
| Q2 FY2008 | 5 Aug 2008 | 2.48 | 443.40M | 178.50M |
| Q1 FY2008 | 31 Mar 2008 | 2.70 | 419.80M | 155.70M |
| Q4 FY2007 | 31 Dec 2007 | 2.25 | 412.30M | 182.90M |
| Q3 FY2007 | 30 Sept 2007 | 2.69 | 436.60M | 162.20M |
| Q2 FY2007 | 30 Jun 2007 | 3.03 | 452.30M | 149.10M |
| Q1 FY2007 | 31 Mar 2007 | 2.82 | 432.20M | 153.30M |
| Q4 FY2006 | 31 Dec 2006 | 1.80 | 281.70M | 156.90M |
| Q3 FY2006 | 30 Sept 2006 | 1.80 | 285.80M | 158.50M |
| Q2 FY2006 | 30 Jun 2006 | 1.93 | 283.20M | 146.60M |
| Q1 FY2006 | 31 Mar 2006 | 1.97 | 263.20M | 133.40M |
| Q4 FY2005 | 31 Dec 2005 | 1.90 | 237.20M | 124.80M |
| Q3 FY2005 | 30 Sept 2005 | 1.78 | 217.80M | 122.60M |
| Q2 FY2005 | 30 Jun 2005 | 2.26 | 255.70M | 113.20M |
| Q1 FY2005 | 31 Mar 2005 | 2.25 | 223.00M | 99.00M |
| Q4 FY2004 | 31 Dec 2004 | 1.94 | 226.50M | 116.50M |
| Q3 FY2004 | 30 Sept 2004 | 2.04 | 218.90M | 107.30M |
| Q2 FY2004 | 30 Jun 2004 | 1.93 | 208.50M | 108.10M |
| Q1 FY2004 | 31 Mar 2004 | 1.77 | 194.80M | 109.80M |
| Q4 FY2003 | 31 Dec 2003 | 1.82 | 216.70M | 118.90M |
| Q3 FY2003 | 30 Sept 2003 | 1.86 | 193.40M | 104.20M |
| Q2 FY2003 | 30 Jun 2003 | 1.91 | 189.30M | 99.10M |
| Q1 FY2003 | 31 Mar 2003 | 1.86 | 172.50M | 92.70M |
| Q4 FY2002 | 31 Dec 2002 | 1.84 | 161.30M | 87.70M |
| Q3 FY2002 | 30 Sept 2002 | 2.06 | 154.70M | 75.10M |
| Q2 FY2002 | 30 Jun 2002 | 1.84 | 153.50M | 83.50M |
| Q1 FY2002 | 31 Mar 2002 | 1.82 | 152.40M | 83.70M |
| Q4 FY2001 | 31 Dec 2001 | 2.10 | 158.50M | 75.30M |
| Q3 FY2001 | 30 Sept 2001 | 1.82 | 183.20M | 100.70M |
| Q2 FY2001 | 30 Jun 2001 | 1.90 | 172.60M | 90.70M |
| Q1 FY2001 | 31 Mar 2001 | 2.00 | 173.80M | 86.80M |
| Q4 FY2000 | 31 Dec 2000 | 2.18 | 173.10M | 79.30M |
| Q3 FY2000 | 30 Sept 2000 | 2.34 | 182.90M | 78.10M |
| Q2 FY2000 | 30 Jun 2000 | 2.06 | 178.10M | 86.60M |
| Q1 FY2000 | 31 Mar 2000 | 1.45 | 193.40M | 133.50M |
| Q4 FY1999 | 31 Dec 1999 | 1.78 | 184.70M | 104.00M |
| Q3 FY1999 | 30 Sept 1999 | 2.10 | 175.80M | 83.60M |
| Q2 FY1999 | 30 Jun 1999 | 2.26 | 176.40M | 78.20M |
| Q1 FY1999 | 31 Mar 1999 | 2.40 | 162.50M | 67.60M |
| Q4 FY1998 | 31 Dec 1998 | 1.53 | 159.70M | 104.20M |
| Q3 FY1998 | 30 Sept 1998 | 2.04 | 186.30M | 91.50M |
| Q2 FY1998 | 30 Jun 1998 | 2.42 | 181.90M | 75.20M |
| Q1 FY1998 | 31 Mar 1998 | 1.91 | 199.50M | 104.70M |
| Q4 FY1997 | 31 Dec 1997 | 2.94 | 170.70M | 58.00M |
| Q3 FY1997 | 30 Sept 1997 | 2.63 | 174.60M | 66.40M |
| Q2 FY1997 | 30 Jun 1997 | 2.61 | 167.70M | 64.20M |
| Q1 FY1997 | 31 Mar 1997 | 2.40 | 167.30M | 69.70M |
| Q4 FY1996 | 31 Dec 1996 | 2.39 | 156.70M | 65.60M |
| Q3 FY1996 | 30 Sept 1996 | 1.98 | 147.70M | 74.70M |
| Q2 FY1996 | 30 Jun 1996 | 2.20 | 149.10M | 67.80M |
| Q1 FY1996 | 31 Mar 1996 | 2.05 | 151.40M | 73.80M |
| Q4 FY1995 | 31 Dec 1995 | 2.40 | 148.40M | 61.80M |
| Q3 FY1995 | 30 Sept 1995 | 2.49 | 155.10M | 62.20M |
| Q2 FY1995 | 30 Jun 1995 | 1.66 | 156.10M | 93.80M |
| Q1 FY1995 | 31 Mar 1995 | 2.51 | 147.60M | 58.90M |
| Q4 FY1994 | 31 Dec 1994 | 1.58 | 136.70M | 86.30M |
| Q3 FY1994 | 30 Sept 1994 | 1.63 | 119.80M | 73.50M |
| Q2 FY1994 | 30 Jun 1994 | 1.70 | 115.60M | 68.20M |
| Q1 FY1994 | 31 Mar 1994 | 1.95 | 107.40M | 55.20M |
| Q4 FY1993 | 31 Dec 1993 | 1.99 | 93.20M | 46.80M |
| Q3 FY1993 | 30 Sept 1993 | 1.87 | 96.70M | 51.80M |
| Q2 FY1993 | 30 Jun 1993 | 1.81 | 101.80M | 56.30M |
| Q1 FY1993 | 31 Mar 1993 | 1.76 | 101.20M | 57.60M |
| Q4 FY1992 | 31 Dec 1992 | 1.62 | 98.70M | 60.90M |
| Q3 FY1992 | 30 Sept 1992 | 1.45 | 101.40M | 69.80M |
| Q2 FY1992 | 30 Jun 1992 | 1.53 | 99.70M | 65.20M |
| Q1 FY1992 | 31 Mar 1992 | 1.52 | 102.00M | 67.20M |
| Q4 FY1991 | 31 Dec 1991 | 1.37 | 97.40M | 70.90M |
| Q3 FY1991 | 30 Sept 1991 | 1.58 | 93.20M | 59.10M |
| Q2 FY1991 | 30 Jun 1991 | 1.51 | 95.10M | 63.10M |
| Q1 FY1991 | 31 Mar 1991 | 1.57 | 105.20M | 66.80M |
| Q4 FY1990 | 31 Dec 1990 | 1.56 | 101.20M | 64.70M |
| Q3 FY1990 | 30 Sept 1990 | 2.03 | 105.40M | 52.00M |
| Q2 FY1990 | 30 Jun 1990 | 1.93 | 108.00M | 55.90M |
| Q1 FY1990 | 31 Mar 1990 | 2.15 | 104.00M | 48.40M |
| Q4 FY1989 | 31 Dec 1989 | 2.07 | 97.40M | 47.00M |
| Q3 FY1989 | 30 Sept 1989 | — | — | — |
| Q2 FY1989 | 30 Jun 1989 | — | — | — |
| Q1 FY1989 | 31 Mar 1989 | — | — | — |
| Q4 FY1988 | 31 Dec 1988 | 2.22 | 96.50M | 43.50M |
| Q3 FY1988 | 30 Sept 1988 | — | — | — |
| Q2 FY1988 | 30 Jun 1988 | — | — | — |
| Q1 FY1988 | 31 Mar 1988 | — | — | — |
| Q4 FY1987 | 31 Dec 1987 | 2.01 | 89.90M | 44.70M |
| Q3 FY1987 | 30 Sept 1987 | — | — | — |
| Q2 FY1987 | 30 Jun 1987 | — | — | — |
| Q1 FY1987 | 31 Mar 1987 | — | — | — |
| Q4 FY1986 | 31 Dec 1986 | 1.83 | 78.50M | 42.90M |
| Q3 FY1986 | 30 Sept 1986 | — | — | — |
| Q2 FY1986 | 30 Jun 1986 | — | — | — |
| Q1 FY1986 | 31 Mar 1986 | — | — | — |
| Q4 FY1985 | 31 Dec 1985 | 3.47 | 56.50M | 16.30M |
| Q3 FY1985 | 30 Sept 1985 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,All ratios
Common questions about West Pharmaceutical Services's current ratio
Source: Financial Modeling Prep
